Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1996
08/18/1996CA2168303A1 Azepinone compounds useful in the inhibition of ace and nep
08/15/1996WO1996024684A1 Potentiators of antibacterial agents
08/15/1996WO1996024676A1 Bioactive fusion proteins and pre-existing tumor therapy
08/15/1996WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS
08/15/1996WO1996024668A1 Human chemokine beta-11 and human chemokine alpha-1
08/15/1996WO1996024611A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996WO1996024588A1 Bicyclic isothiourea derivatives useful in therapy
08/15/1996WO1996024572A1 Method for purifying diacetyl rhein
08/15/1996WO1996024378A2 Delivery of exogenous compounds
08/15/1996WO1996024372A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1996024370A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996WO1996024363A1 Therapeutic methods and preparations using rubidium ions
08/15/1996WO1996024356A1 Methods of inhibiting effects of il-6
08/15/1996WO1996024349A1 Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases
08/15/1996WO1996024343A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
08/15/1996WO1996016652A3 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections
08/15/1996WO1996013598A3 Hybrid adenovirus-aav virus and method of use thereof
08/15/1996WO1996011685A3 Use of indole derivatives for the treatment of various diseases
08/15/1996WO1994020062A3 Balanoids as protein kinase c inhibitors
08/15/1996CA2212712A1 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/15/1996CA2212682A1 Delivery of exogenous compounds
08/15/1996CA2212645A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2212520A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996CA2212464A1 Potentiators of antibacterial agents
08/15/1996CA2212232A1 Methods of inhibiting effects of il-6
08/15/1996CA2212054A1 Gnrh-leukotoxin chimeras
08/15/1996CA2211299A1 Bicyclic isothiourea derivatives useful in therapy
08/15/1996CA2210955A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996CA2187460A1 Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases
08/14/1996EP0726273A1 Tocophenylglycoxides, their preparation and use as tensides, as antioxidants and as cells altering prophylactics in cosmetic or pharmaceutical preparation
08/14/1996EP0726267A1 Quinazoline derivative
08/14/1996EP0726265A1 10-Aminoaliphatyl-dibenz(b,f)oxepins with antineurodegenarative activity
08/14/1996EP0726075A1 Pharmaceutical non-inorganic saline solutions for endonasal administration
08/14/1996EP0726074A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof
08/14/1996EP0726073A2 Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine
08/14/1996EP0726072A2 Composition for the treatment of hypertension and congestive heart failure, containing an angiotensin II antagonist and an endopeptidase inhibitor
08/14/1996EP0725826A1 Improvements relating to cancer therapy
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725791A1 Recombinant p53 adenovirus methods and compositions
08/14/1996EP0725782A1 Novel a 1 adenosine receptor agonists and antiagonists
08/14/1996EP0725775A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
08/14/1996EP0725654A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
08/14/1996EP0725651A1 Hemoregulatory peptides
08/14/1996EP0725650A1 Inhibitors of farnesyl-protein transferase
08/14/1996EP0725649A1 Class i mhc modulation of surface receptor activity
08/14/1996EP0725641A1 Novel enzyme inhibitors, their synthesis, and methods for use
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0670826A4 Fatty acid derivatives and pharmaceutical compositions containing them.
08/14/1996EP0660823B1 N-cyano-n'-pyridylguanidines as serotonin antagonists
08/14/1996CN1129013A New growth-differentiation factor of the TGF-beta family
08/14/1996CN1128987A Novel intermediates for prepn. of antihisatminic 4-diphenylmethyl/diphenymethoxy piperidine derivatives
08/14/1996CN1128952A Method for preventing neutrophil mediated connective tissue damage
08/14/1996CN1128762A Benzyl piperidine derivatives
08/14/1996CN1128757A 1,4-dihydro pyridine-3,5-dicarboxylic ester
08/14/1996CN1128756A Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatves as selective human NK3-receptor antagonists
08/14/1996CN1128752A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof
08/14/1996CN1128655A Injectable liposomal pharmaceutical prepn.
08/14/1996CN1032534C Method for prepn. of diaminotrifluoromethylpyridine derivatives
08/13/1996US5545838 Hypotensive agents
08/13/1996US5545738 Useful for production of antihypertensive agents and dysurea curing agents
08/13/1996US5545736 6-thiono-5,6-dihydro-dibenz[B,E] azepin-11-one-11-oximes
08/13/1996US5545723 Amino acid sequence where valine at position 101 is replaced with phenylalanine, tyrosine, tryptophan or histidine; diplayes an antiviral activity, that is atleast partially neutralized by antibodies to wild type interferon-beta
08/13/1996US5545720 Protein PHBP-70
08/13/1996US5545669 Anti-inflammatory compounds
08/13/1996US5545662 Used to accelerate recovery from neutropenia accompanying radio or chemotherapy, bone marrow transplantation, or infections
08/13/1996US5545643 Useful for treating diseases of central nervous system
08/13/1996US5545641 Methods of inhibiting physiological conditions associated with an excess of bradykinin
08/13/1996US5545635 Inhibiting bone loss with equilenin
08/13/1996US5545633 Triplet-sensitized photoisomerization; dehydration; protecting; deprotecting; separation
08/13/1996US5545614 Controlling nitrogen oxide concentrations to modulate skeletal muscle contraction
08/13/1996US5545569 Immobilizing capture moiety that binds transforming growth factor-beta, adding serum from patient to form capture complex, adding labeled signal moiety that binds with complex, determining detectable label, presence of factor
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/11/1996CA2169247A1 Pharmaceutical compositions and method for the treatment of patients having fragile x syndrome and retarded maturities or affected by alzheimer's type diseases or huntington's chorea or who show similar symptoms of muscular hypotonie and similar s ates
08/11/1996CA2169136A1 Use of src sh2 specific compounds to treat a bone resorption disease
08/11/1996CA2169132A1 Use of hcp sh2 specific compounds to enhance erythropoiesis
08/09/1996CA2168066A1 Treatment of hypertension and congestive heart failure
08/08/1996WO1996023883A2 Modified ligands for receptor tyrosine kinases
08/08/1996WO1996023791A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023785A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
08/08/1996WO1996023783A1 Indole derivatives as 5-ht receptor antagonist
08/08/1996WO1996023769A2 Heterocyclic compounds possessing 5ht2c receptor antagonist activity
08/08/1996WO1996023727A1 Process for producing hydrotalcites and their metal oxides
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023509A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/08/1996WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996WO1996023504A2 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates
08/08/1996WO1996023493A1 New pharmaceutical composition containing trimebutine and preparation process
08/08/1996WO1996023414A1 Properties of cats' facial pheromones
08/08/1996WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9
08/08/1996DE19521046C1 DNA encoding DNase and related vectors, host cells and antibodies
08/08/1996DE19503522A1 Herstellung gemischter schichtförmig aufgebauter Metallhydroxide sowie deren Metalloxide Preparation of mixed-stratified metal hydroxides and their metal oxides
08/08/1996DE19503190A1 Mittel zur Beeinflussung von Störungen der Knochenbildung Means for influencing of disorders of bone formation
08/08/1996CA2212236A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996CA2212061A1 Indole derivatives as 5-ht receptor antagonist
1 ... 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 ... 1564